"TO THRIVE AS A FIELD, DIGITAL MEDICINE REQUIRES AN UNPRECEDENTED LEVEL OF INTERDISCIPLINARY COLLABORATION. FROM REGULATORS TO WHITE-HAT HACKERS, ETHICISTS TO ENGINEERS, AND CLINICIANS TO CITIZEN SCIENTISTS, NEW COOPERATIVE NETWORKS MUST EMERGE TO ENSURE THAT DIGITAL MEDICINE REALIZES ITS FULL POTENTIAL TO IMPROVE HUMAN HEALTH." (DIGITAL MEDICINE SOCIETY)
Returning to Pfizer in Cambridge, the Digital Implementation Forum focuses on ways for life sciences to take advantage of new opportunities within digital health and digital measurement; as well as how these new data can supplement existing collection strategies to drive research forward. Be a part of the movement to get these validated digital measures and digital health tools (DHTs) into the hands of patients, their physicians and caregivers.
Join 30+ speakers, 150 senior-level pharma, clinical trials, technology and digital health executives this November 13, 2024 at Pfizer in Cambridge to learn, network, develop and improve the way digital health measurement tools are being created, validated, scaled and deployed in life sciences to improve data quality, improve patient experience & accelerate drug development and patient care.
Join 30+ speakers, 150 senior-level pharma, clinical trials, technology and digital health executives this November 13, 2024 at Pfizer in Cambridge to learn, network, develop and improve the way digital health measurement tools are being created, validated, scaled and deployed in life sciences to improve data quality, improve patient experience & accelerate drug development and patient care.
Location
Date & Time
November 13, 2024
9:00am - 5:30pm
9:00am - 5:30pm
JUST RELEASED! 2024 CORE THEMES!
1. What is the Value Proposition for Digital Tools to Stakeholders in Clinical Research: Patients, Payers, HCPs, Sites & Regulators
• From the perspective of patients, what sort of value can be delivered with the integration of digital tools; and how much measurement is too much?
• From the perspective of HCPs, how digital can improve the patient care scenario and without being overly burdensome
• From a payer perspective, how can this be integrated into your care optimization pathway to improve outcomes
• How to streamline the Deployment of Digital Tools in Clinical Research to be as frictionless as possible for clinical research sites
• Site Partners talk about improving the process from the operations standpoint
2. "How To" Session
• How to engage with patients directly about measures that matter to them
• How to engage with sites to determine existing workflows and best operationalize deployment of additional digital resources
• How to convince project teams that it is a good idea to implement more digital into study protocols
3. Operationalizing Digital Measurement Tools & Closing Discussions
• The latest advances in Digital Endpoints and the State of the Space
2024 Speakers and Advisors
Carrie Northcott
Sr. Director, Head of Digital Sciences
(Conference Chair)
Sr. Director, Head of Digital Sciences
(Conference Chair)
PFIZER
Tim McCarthy
VP, Head of Digital Sciences & Translational Imaging
VP, Head of Digital Sciences & Translational Imaging
PFIZER
Xuemei Cai
Sr. Director, Head of Clinical Research
Sr. Director, Head of Clinical Research
PFIZER
Edward Cox
Head & General Manager of Digital Health and Medicines (DHM)
Head & General Manager of Digital Health and Medicines (DHM)
PFIZER
Joseph DiMasi
Director of Economic Analysis, Center for the Study of Drug Development
Director of Economic Analysis, Center for the Study of Drug Development
TUFTS UNIVERSITY
Tarik Yardibi
Director, Sensing & Measurement
Director, Sensing & Measurement
TAKEDA
Samantha Reyes
Patient Engagement Lead
Patient Engagement Lead
SANOFI
Abigail Newell
Director of Research
Director of Research
CANCER SUPPORT COMMUNITY
Ann-Marie Richard
Director and Patient Engagement Lead
Director and Patient Engagement Lead
PFIZER
Kristal Hartman
Obesity Patient Advocate
Obesity Patient Advocate
OBESITY ACTION COALITION
Joss Langford
CTO
CTO
ACTIVINSIGHTS
Federico Parisi
Principal Data Scientist, Data Science & Digital Health
Principal Data Scientist, Data Science & Digital Health
J&J INNOVATIVE MEDICINE
Noman Ashraf
Principal Data Scientist, Data Science & Digital Health
Principal Data Scientist, Data Science & Digital Health
J&J INNOVATIVE MEDICINE
Matteo Lai
CEO
CEO
EMPATICA
Brett Hauber
Senior Director, Patient Preference Expert
Senior Director, Patient Preference Expert
PFIZER
Sachin Shah
Digital Biomarker Lead
Digital Biomarker Lead
GSK
Martha Azer
Associate Director, Regulatory Policy NA
Associate Director, Regulatory Policy NA
J&J INNOVATIVE MEDICINE
Andrew Kaseman
Implementation Manager, Digital Strategy
Implementation Manager, Digital Strategy
TAKEDA
Eric Mangin
Director, Digital Clinical Measures
Director, Digital Clinical Measures
MERCK
Rinol Alaj
Head of Digital Health Technologies
Head of Digital Health Technologies
REGENERON
Isik Karahanoglu
Director, Early Clinical Development, Digital Sciences
Director, Early Clinical Development, Digital Sciences
PFIZER
Jeremy Wyatt
CEO
CEO
ACTIGRAPH
Charmaine Demanuele
Executive Director, Head of Quantitative Sciences
Executive Director, Head of Quantitative Sciences
PFIZER
Gül Erdemli
Global Program Regulatory Director
Global Program Regulatory Director
NOVARTIS
Daniel Kalanovic
VP, Head of Medical Digital Health
VP, Head of Medical Digital Health
PFIZER
Daniel Rooks
Head, Endpoint Management, Clinical Excellence
Head, Endpoint Management, Clinical Excellence
NOVARTIS
Shannon Lubaczewski
Director, Clinician
Director, Clinician
PFIZER
Mar Santamaria
Director, Clinician
Director, Clinician
PFIZER
Milos Todorovic
Director, Biomedical and Clinical Engineering
Director, Biomedical and Clinical Engineering
ANALOG DEVICES
Erin Rainaldi
Head of Data Science for Devices
Head of Data Science for Devices
VERILY
Musaddiq Khan
VP, Customer Value Digital Outcomes and TA Strategy
VP, Customer Value Digital Outcomes and TA Strategy
MEDABLE
Sudeshna Fisch
Director, Translational Medicine Lead (Conference Chair)
Director, Translational Medicine Lead (Conference Chair)
PFIZER
Agenda: November 13, 2024
8:00 AM
Registration, Coffee and Conversation
Conference registration open with continental breakfast and coffee served
9:00 AM
Opening Remarks from Conference Chair
Carrie Northcott, Head of Digital Sciences, Pfizer (Morning Chair)
9:10 AM
What is the Value Proposition for Digital Tools to Stakeholders in Clinical Research: Study Teams, Payers, HCPs, Sites & Regulators
9:10 AM
Developing a Novel Digital Endpoint for Cancer Cachexia: Path to Regulatory Qualification
Isik Karahanoglu, Director, Early Clinical Development, Digital Sciences & Translational Imaging Quantitative Sciences, Pfizer
9:30 AM
Continuing the Regulatory Acceptance Journey for Successful use of DHTs
Martha Azer, Associate Director, Regulatory Policy NA, Johnson & Johnson Innovative Medicine
9:45 AM
How to build a Digital Biomarker in a Commercial Setting: Seizure Forecasting with the Only FDA-Cleared Epilepsy Monitor
Matteo Lai, CEO, Empatica
10:05 AM
PANEL DISCUSSION: What is the Value Proposition for Digital Tools to Stakeholders in Clinical Research: Patients, Payers, HCPs, Regulators
Tim McCarthy, VP, Head of Digital Sciences & Translational Imaging, Pfizer
Rinol Alaj, Head of Digital Health Technologies, Regeneron
Gül Erdemli, Global Program Regulatory Director, Novartis
Daniel Kalanovic, VP, Head of Medical Digital Health, Pfizer
Led by Xuemei Cai, Sr. Director, Head of Clinical Research, Pfizer
10:30 AM
NETWORKING COFFEE BREAK
11:00 aM
Beyond Wearables: Digital Implementation in Clinical Settings
Andrew Kaseman, Implementation Manager, Digital Strategy, Takeda
11:20 aM
Digital Measure Development, Adoption, and Operationalisation
Joss Langford, CTO, Activinsights
11:40 aM
Patient Compliance to Wearing an Actigraphy Device and its Effect on the Estimation of Actigraphy-Derived Measures of Exercise Capacity in Pulmonary Arterial Hypertension
Federico Parisi, Principal Data Scientist, Data Science & Digital Health, Johnson & Johnson Innovative Medicine
Noman Ashraf, Data Scientist, Data Science & Digital Health, Johnson & Johnson Innovative Medicine
12:00 PM
PANEL DISCUSSION: How to streamline the Deployment & Implementation of Digital Tools in Clinical Research to be as Frictionless as Possible
Erin Mangin, Director, Digital Clinical Measures, Merck
Andrew Kaseman, Implementation Manager, Digital Strategy, Takeda
Shannon Lubaczewski, Director, Clinician, Pfizer
Milos Todorovic, Director, Biomedical and Clinical Engineering, Analog Devices
Led by Charmaine Demanuele, Executive Director, Head of Quantitative Sciences, Pfizer
12:25 PM
NETWORKING LUNCHEON
1:15 PM
"How To" Session
• How to engage with patients directly about measures that matter to them
• How to engage with sites to determine existing workflows and best operationalize deployment of additional digital resources
• How to convince project teams that it is a good idea to implement more digital into study protocols
1:15 PM
Afternoon Introductions from Conference Chair
Sudeshna Fisch, Director, Translational Medicine Lead, Pfizer (Afternoon Chair)
1:20 PM
Possibilities and Promise of Leveraging Digital Measures To Benefit all Stakeholders in Clinical Research
Edward Cox, Head & General Manager of Digital Health and Medicines (DHM), Pfizer
1:35 PM
Assessing the Net Financial Benefits of Employing Digital Endpoints in Clinical Trials
Joe DiMasi, Director of Economic Analysis, Tufts University Center for the Study of Drug Development
1:50 PM
Oncology Patient Advocacy and Patient Preference
Abigail Newell, Director, Research, Cancer Support Community
Brett Hauber, Sr Director, Patient Preference Expert, Pfizer
2:10 PM
How to Engage with Patients Directly about Measures that Matter to Them
Samantha Reyes, Patient Engagement Lead, Sanofi
2:25 PM
PANEL DISCUSSION: The Imperative of Patient Engagement in driving DHTs into Wider Use as Clinical Tools / Digital Therapeutics
Abigail Newell, Director, Research, Cancer Support Community
Kristal Hartman, Obesity Patient Advocate, Obesity Action Coalition
Brett Hauber, Sr Director, Patient Preference Expert, Pfizer
Samantha Reyes, Patient Engagement Lead, Sanofi
Ann-Marie Richard, Director and Patient Engagement Lead, Early Clinical Sciences, Pfizer
Moderated by Carrie Northcott, Head of Digital Sciences, Pfizer
2:50 PM
NETWORKING COFFEE AND REFRESHMENT BREAK
3:20 PM
Operationalizing Digital Measurement Tools
3:20 PM
Lessons Learned in Parkinson's Disease Endpoint Development
Erin Rainaldi, Head of Data Science for Devices, Verily
3:40 PM
Turning Trials into Triumphs: from Insights to Action
Jeremy Wyatt, CEO, Actigraph
4:00 PM
PANEL DISCUSSION: Operationalizing Digital Measurement Tools
Tarik Yardibi, Director, Sensing & Measurement, Takeda
Sachin Shah, Digital Biomarker Lead, GSK
Jeremy Wyatt, CEO, Actigraph
Daniel Rooks, Head, Endpoint Management, Clinical Excellence, Novartis
Musaddiq Khan, VP - Customer Value, Digital Outcomes and TA Strategy, Medable
Moderated by Mar Santamaria, Clinician, Sr. Director, Pfizer
4:25 - 5:30 PM
NETWORKING RECEPTION
HOST SPONSOR
GOLD SPONSOR
GOLD SPONSOR
GOLD SPONSOR
GOLD SPONSOR
SILVER SPONSOR
SILVER SPONSOR
EXHIBITOR
SUPPORTING SPONSOR
Interested in Sponsorship & Exhibition Opportunities?
Location
Pfizer Innovation Research (PfIRe) Lab
Cambridge, MA
Cambridge, MA
The PfIRe Lab is a highly instrumented clinical research facility located in Cambridge, Massachusetts. Here, researchers use cutting-edge wearable and environmental sensors to develop and validate novel, patient-centric clinical endpoints, thereby potentially enabling a better understanding of a patient’s disease state and response to therapy.
Pfizer’s Digital Medicine & Translational Imaging Team recently unveiled this industry-leading facility in Cambridge, Massachusetts, designed to rapidly evaluate and validate novel technologies for potential use in clinical trials. In the PfIRe Lab, a multidisciplinary team of clinicians and researchers utilize state-of-the-art motion capture technologies, coupled with environmental and wearable sensors to develop new patient-centric clinical trial endpoints, enabling measures of physical function and activity outside of the traditional hospital and clinical settings.
Pfizer’s Digital Medicine & Translational Imaging Team recently unveiled this industry-leading facility in Cambridge, Massachusetts, designed to rapidly evaluate and validate novel technologies for potential use in clinical trials. In the PfIRe Lab, a multidisciplinary team of clinicians and researchers utilize state-of-the-art motion capture technologies, coupled with environmental and wearable sensors to develop new patient-centric clinical trial endpoints, enabling measures of physical function and activity outside of the traditional hospital and clinical settings.
Join us at the
Digital Implementation Summit 2024!
Digital Implementation Summit 2024!
The Premiere Event focused on Digital Measurements Developed for Clinical Research to ultimate Clinical Utility; for the Benefit of Patients and their Healthcare Providers